text
stringlengths 28
3.85k
|
|---|
Ataxic hemiparesis (Hemiparesis) Ataxia which has finding site Axi, Cerebrospinal |
Clinical Medical Laboratory (Manufactured Object) HealthcareProviderTaxonomyHIPAA - CodeSystem which is specialty of Lidocaine measurement |
Incontinence;bowel (Physical & Psychosomatic Disorders) Nursing Assessment Entity which has actual outcome Improved |
Difficulty managing stairs backwards (Difficulty managing stairs) Difficulty managing stairs which interprets Ability to manage stairs backwards |
No purpose in life:Find:Pt:^Patient:Ord:Reported.living-HIV (Clinical Attribute) something which has method Reported.living-HIV |
Long-term current use of secukinumab (Drug therapy status) Drug therapy status which is a Drug therapy status |
Acquired deformity (Acquired skeletal deformity) DISPLACEMENTS AND DEFORMITIES which is associated morphology of Other deformity of hallux |
milestone: drinks from a cup (Finding) Finding which is a Finding of infant milestone |
No transformation (Mix) Mix which is pharmaceutical transformation of Coated granules |
Cleft hard palate with cleft soft palate (Congenital abnormality of respiratory system) Cleft Soft Palate which is a respiratory system; anomaly |
Destructive procedure (Actions by primitive) Actions by primitive which is method of Destruction of cranial nerve or ganglion |
hypertensive heart disease; with hypertensive kidney disease (Disease or Syndrome) Kidney Diseases which is classified as hypertensive nephropathy |
Complera (Pharmacologic Substance) Pharmacologic Substance which is tradename of tenofovir disoproxil |
Structure of trabecula carnea of right ventricle (Inferior wall of right ventricle) Anterior wall of right ventricle which is sib in isa Structure of vincula tendinum of foot |
milliliter (Quantitative Concept) Unit of volume which is presentation strength denominator unit of Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter conventional release suspension for injection ampule |
dermatofibrosarcoma; protuberans, pigmented (dermatofibrosarcoma of skin) Primary malignant neoplasm which is a Neoplasm of uncertain behavior of skin, NOS |
Pennsylvania (Great Lakes Region) something which has conceptual part PA083 |
ethyl 8'-methyl-2',4-dioxo-2-(piperidin-1-yl)-2'H-spiro(cyclopentane-1,3'-imidazo(1,2-a)pyridin)-2-ene-3-carboxylate (Pharmacologic Substance) Pharmacologic Substance which is mapped to Imidazoles |
Ethinyloestradiol [malignancy] (ethinyl estradiol) Estrogenic Steroids, Alkylated which is active ingredient of Ethinyl Estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet |
Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (Product manufactured as oromucosal dose form) Compound anaesthetic topical preparation which is a Compound anaesthetic topical preparation |
dl-Alpha-Tocopheryl Acetate (tocopherol acetate) D [Preparations] which is inactive ingredient of LIDOCAINE HYDROCHLORIDE 4 g in 100 mL TOPICAL CREAM [SERA RELIEF ULTIMATE RAPID SOOTHING CREME] |
HOTTONIA PALUSTRIS FLOWER (generic drug products begining with the letter H) Organic Chemical which is active moiety of AGRIMONIA EUPATORIA 30 [hp C] in 60 mL / POPULUS ALBA WHOLE 30 [hp C] in 60 mL / FAGUS SYLVATICA FLOWERING TOP 30 [hp C] in 60 mL / CERATOSTIGMA WILLMOTTIANUM FLOWER 30 [hp C] in 60 mL / PRUNUS CERASIFERA FLOWER 30 [hp C] in 60 mL / AESCULUS HIPPOCASTANUM WHOLE 30 [hp C] in 60 mL / CICHORIUM INTYBUS FLOWER 30 [hp C] in 60 mL / MALUS SYLVESTRIS FLOWER 30 [hp C] in 60 mL / ULMUS ALATA WHOLE 30 [hp C] in 60 mL / GENTIANA ACAULIS 30 [hp C] in 60 mL / ULEX EUROPAEUS FLOWER 30 [hp C] in 60 mL / CALLUNA VULGARIS FLOWERING TOP 30 [hp C] in 60 mL / ILEX AQUIFOLIUM FLOWERING TOP 30 [hp C] in 60 mL / LONICERA CAPRIFOLIUM FLOWERING TOP 30 [hp C] in 60 mL / CARPINUS BETULUS FLOWERING TOP 30 [hp C] in 60 mL / IMPATIENS CAPENSIS WHOLE 30 [hp C] in 60 mL / LARIX DECIDUA WHOLE 30 [hp C] in 60 mL / MIMULUS GUTTATUS FLOWERING TOP 30 [hp C] in 60 mL / BRASSICA NIGRA WHOLE 30 [hp C] in 60 mL / QUERCUS ROBUR FLOWER 30 [hp C] in 60 mL / OLEA EUROPAEA FRUIT VOLATILE OIL 30 [hp C] in 60 mL / PINUS SYLVESTRIS FLOWERING TOP 30 [hp C] in 60 mL / AESCULUS CARNEA FLOWER 30 [hp C] in 60 mL / HELIANTHEMUM NUMMULARIUM FLOWER 30 [hp C] in 60 mL / SCLERANTHUS ANNUUS FLOWERING TOP 30 [hp C] in 60 mL / ORNITHOGALUM UMBELLATUM 30 [hp C] in 60 mL / CASTANEA SATIVA FLOWER 30 [hp C] in 60 mL / VERBENA OFFICINALIS FLOWERING TOP 30 [hp C] in 60 mL / VITIS VINIFERA FLOWERING TOP 30 [hp C] in 60 mL / JUGLANS REGIA FLOWERING TOP 30 [hp C] in 60 mL / HOTTONIA PALUSTRIS FLOWER 30 [hp C] in 60 mL / AESCULUS HIPPOCASTANUM FLOWER 30 [hp C] in 60 mL / AVENA FATUA WHOLE 30 [hp C] in 60 mL / ROSA CANINA FLOWER 30 [hp C] in 60 mL / SALIX ALBA FLOWERING TOP 30 [hp C] in 60 mL / ADENOSINE TRIPHOSPHATE 5 [hp X] in 60 mL / BOS TAURUS PINEAL GLAND 6 [hp C] in 60 mL / BOS TAURUS THYMUS 6 [hp C] in 60 mL ORAL SOLUTION/ DROPS |
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS (Disease or Syndrome) Disease or Syndrome which has manifestation Near- to low-normal hematocrit |
Octinoxate 50 mg in 1 mL TOPICAL LIQUID [Purminerals 4-in-1 14-Hour Wear Foundation Broad Spectrum SPF 15 (BLUSH MEDIUM)] (Substance) Substance which has inactive ingredient trihydroxystearin |
Brucella spondylitis (Brucellosis) Gram-Negative Bacterial Infections which has finding site Joints |
Excision or biopsy of axillary lymph node (Procedure on lymph node) Procedure on lymph node which has method Biopsy |
Mechanical complication of ventricular communicating shunt (Disorder of brain ventricular shunt) Mechanical complication of nervous system device which is a Mechanical complication of nervous system implant |
Altretamine/Cisplatin/Etoposide/Mitomycin (Therapeutic or Preventive Procedure) Therapeutic or Preventive Procedure which is mapped to 4'-Demethylepipodophyllotoxin 9-[4,6-O-ethylidene-beta-D-glucopyranoside] |
MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NO, SO:-:Pt:^Patient:-:CMS Assessment (PANEL.SURVEY.CMS) Clinical Attribute which has member Nutritional approaches:-:Point in time:^Patient:- |
YES (Finding) Finding which is answer to Plan of care includes patient-specific parameters for notifying physician of changes:Find:Pt:^Patient:Ord:CMS Assessment |
Giardia sp Ag:PrThr:Pt:Stool:Ord:IA.rapid (Microbiology - Laboratory Class) something which has component Giardia sp Ag |
3 ML Insulin Glargine 100 UNT/ML Pen Injector [Lantus] (Clinical Drug) Clinical Drug which has inactive ingredient water |
FDA Center For Devices and Radiological Health Terminology (Functional Concept) Functional Concept which is subset includes concept IRREGULAR PULSE |
On examination - locked joint (O/E - abnormal joint movement) O/E - joint abnormal which has associated finding Locking of joint |
Glomus Tympanicum Tumor (Middle Ear Paraganglioma) Neoplastic Process which is disease has primary anatomic site base of skull |
localized pain (Localized allergic response status) Observation of pattern of pain which is classified as Pain |
Cervix Diseases (Diagnosis/Diseases Component) Uterine cervix finding which is mapped from Trophic ulcer of uterine cervix |
Intellectual disability, obesity, prognathism, eye and skin anomalies syndrome (Skin Abnormalities) something which has associated morphology Anomaly |
Brain cerebrospinal fluid pathway (Central nervous system space) Brain which is procedure site of Attention to ventper shunt NOS |
abscess of vas deferens of left testicle (Abscess of vas deferens) something which has laterality left sided |
oxybenzone (Organic Chemical) Sunscreening Agents which is active ingredient of Oxybenzone 0.56 mL in 14 mL / Avobenzone 0.28 mL in 14 mL / Octisalate 0.7 mL in 14 mL / Homosalate 1.4 mL in 14 mL / OCTOCRYLENE 0.28 mL in 14 mL TOPICAL CREAM [Timewise Day Solution sunscreen SPF 35 14ml] |
Device malfunction (Device malfunction events NEC) Device malfunction events NEC which classifies Diagnostic device malfunction |
SALICYLIC ACID 2% TOP BAR (Clinical Drug) Clinical Drug which is a KERATOLYTICS/CAUSTICS,TOPICAL |
Open wound of vulva with complication (Open wound of trunk) Open wound of pelvic region with complication which has finding site Skin structure |
ureter(o)- (Upper urinary tract structure) Ureter which is direct procedure site of Intravesical and extravesical bilateral ureteric reimplantation |
Choriogonadotropin.beta subunit:MoM:Pt:Ser/Plas:Qn (Choriogonadotropin.beta subunit | Serum or Plasma | Chemistry - non-challenge) Clinical Attribute which has system Plasmas, Blood |
Partial anodontia (Hypodontia) Developmental absence of tooth which has associated morphology Congenital developmental anomaly |
Parasitic cirrhosis (Infection of digestive system) Infectious cirrhosis which is a Endoparasitism |
Gastrointestinal system (Croatian translation of the Medical Subject Headings) German translation of the Medical Subject Headings which is primary anatomic site of disease squamous cell papilloma of anal canal |
Second dorsal metatarsal artery (Structure of dorsal metatarsal artery) Structure of dorsal metatarsal artery which has regional part Lateral part of dorsal digital artery of second toe |
Referral to tinnitus management service (Health Care Activity) Health Care Activity which has priority routines |
Rhesus isoimmunization affecting management of mother, antepartum condition (Rhesus isoimmunisation affecting management of mother) Rhesus isoimmunisation affecting management of mother which is classified as incompatibilities rh |
Lymphoma (Primary malignant neoplasm) Primary malignant neoplasm which classifies Other malignant lymphomas, intrathoracic lymph nodes |
Entire tributary of deep palmar venous arch (Body Part, Organ, or Organ Component) Structure of tributary of deep palmar venous arch which is entire anatomy structure of Structure of tributary of deep palmar venous arch |
ABCA1 protein, human (Translocase) Enzyme which is a ATP-Binding Cassette Transporters |
lacosamide 150 MG (Clinical Drug) Clinical Drug which has tradename lacosamide 150 MG [Vimpat] |
Closed reduction of injury to growth plate and internal fixation however further qualified (Separated epiphysis - closed reduction) something which has method Reduction - action |
Therapeutic (Functional Concept) something which is intent of Injection of neurolytic nerve agent |
External cause codes: intent of injury, accidental/unintentional (Injury or Poisoning) something which classifies Toxic effect of strychnine and its salts, accidental (unintentional), initial encounter |
Gelsemium sempervirens Root (G [Preparations]) Plant Roots which is active moiety of BAPTISIA TINCTORIA ROOT 3 [hp X] in 1 mL / SOLANUM DULCAMARA TOP 3 [hp X] in 1 mL / ECHINACEA ANGUSTIFOLIA 3 [hp X] in 1 mL / GARLIC 4 [hp X] in 1 mL / PHYTOLACCA AMERICANA ROOT 4 [hp X] in 1 mL / APIS MELLIFERA 30 [hp C] in 1 mL / ARSENIC TRIOXIDE 30 [hp C] in 1 mL / ATROPA BELLADONNA 30 [hp C] in 1 mL / MATRICARIA RECUTITA 30 [hp C] in 1 mL / FERROSOFERRIC PHOSPHATE 30 [hp C] in 1 mL / GELSEMIUM SEMPERVIRENS ROOT 30 [hp C] in 1 mL / LACHESIS MUTA VENOM 30 [hp C] in 1 mL / MERCURIUS SOLUBILIS 30 [hp C] in 1 mL / RANCID BEEF 30 [hp C] in 1 mL ORAL LIQUID [9 Bacterial Detox] |
Fetal or neonatal effect of intraperitoneal ectopic pregnancy (Fetal or neonatal effect of abdominal ectopic pregnancy) Fetal or neonatal effect of abdominal ectopic pregnancy which has finding site Fetal Structures |
Haemorrhagic central nervous system vascular conditions (Classification) something which has member Extradural hemorrhage following injury, without mention of open intracranial wound, with prolonged [more than 24 hours] loss of consciousness and return to pre-existing conscious level |
carnauba wax (Organic Chemical) Industrial Aid which is inactive ingredient of Octinoxate 0.075 g in 1 g TOPICAL LIPSTICK [ESIKA PRO PERFECT MATCH VOLUMEN (CAFE MISTERIO) - BROWN] |
brimonidine (Pharmacologic Substance) Sympathomimetics in glaucoma therapy which has physiologic effect Decreased Intraocular Fluid Pressure |
Cortastat, 4 mg/mL injectable solution (Dexamethasone phosphate 1 MG/ML Ophthalmic Solution) Dexamethasone phosphate 1 MG/ML Ophthalmic Solution which has inactive ingredient MONOSODIUM CITRATE |
Current or specified (Temporal Concept) something which is temporal context of Blood sent for haematology test |
CDISC Questionnaire EPIC-CP Test Code Terminology (CDISC Questionnaire Terminology) something which is subset includes concept EPIC-CP - Problem Lack of Sexual Function |
1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea (oral hypoglycemics) G [Preparations] which is active ingredient of glyburide 2.5 MG Oral Tablet |
Body cavities (Anatomic Structure, System, or Substance) Anatomic Structure, System, or Substance which is finding site of Injury of lung without open wound into thorax |
Right maxilla (Maxilla) something which is sib in part of Head>Temporal bone.right |
CC (Spinal cord part) Spinal Cord which is procedure site of Revision of shunt in spinal syrinx |
Statistics section (Intellectual Product) Intellectual Product which is measured by Clinical trial protocol Statistics section |
Diltiazemum (Anti-Arrhythmia Agents) Calcium Channel Blocker [EPC] which is active moiety of 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Tablet |
purpurase protein, Cryptelytrops purpureomaculatus (Hazardous or Poisonous Substance) Amino Acid, Peptide, or Protein which is mapped to Endopeptidases |
Boron radioisotope, NOS (Radioisotopes) Boron and boron compound which is a Boron isotope |
Anacardium occidentale allergenic extract 0.1 GM/ML Injectable Solution (Clinical Drug) Clinical Drug which has active moiety cashew nut allergenic extract |
Removal of tube from retroperitoneum (Removal of drain) Therapeutic or Preventive Procedure which has method Removal - procedure |
Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage (Neoplastic Process) something which is disease has abnormal cell Neoplastic Small to Medium-Sized T-Lymphocyte |
Tunica mucosa oris (Skin of part of mouth region) Structure of internal part of mouth which is finding site of Amalgam tattoo |
NaCl - Sodium chloride (S [Preparations]) Sodium product which is active ingredient of ARSENIC TRIOXIDE 8 [hp X] in 50 mL / ATROPA BELLADONNA 30 [hp X] in 50 mL / BRYONIA DIOICA ROOT 12 [hp X] in 50 mL / ACTIVATED CHARCOAL 30 [hp X] in 50 mL / ERIODICTYON CALIFORNICUM FLOWERING TOP 12 [hp X] in 50 mL / SUS SCROFA PITUITARY GLAND 30 [hp X] in 50 mL / POTASSIUM PHOSPHATE, DIBASIC 30 [hp X] in 50 mL / SODIUM CHLORIDE 30 [hp X] in 50 mL / SODIUM SULFATE 200 [hp X] in 50 mL / VERATRUM ALBUM ROOT 30 [hp X] in 50 mL ORAL LIQUID [DR. RECKEWEG R43 Herbamine Combination product] |
Poisoning by smallpox vaccine (Injury or Poisoning) Poisoning by other and unspecified vaccines and biological substances which is a Poisoning by viral and rickettsial vaccine, NOS |
aluminium hydroxide (antacids containing aluminium compounds) aluminum hydroxide which is inactive ingredient of Nystatin/Triamcinolone Acetonide 100000 U/1 GM-0.1% Topical application Cream |
lycopene metabolic process (Molecular Function) Molecular Function which is a carotene metabolic process |
Ord (Qualitative Concept) something which is scale of Acetylsalicylate [Presence] in Serum or Plasma |
iodine-deficiency related thyroid disorders (Disease or Syndrome) Thyroid Diseases which is same as Iodine deficiency syndrome |
arabinose (Sugars/Sugar metabolism) Sugars/Sugar metabolism which is a Pentose |
x-ray of femur (Plain x-ray) something which is a X-ray of bones |
Oral tablet (Oral Dosage Form) something which is dose form of benzocaine 20 MG Oral Tablet |
OCTINOXATE 30 mg in 1 mL / TITANIUM DIOXIDE 17.5 mg in 1 mL TOPICAL EMULSION [DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 010] (Substance) Substance which has inactive ingredient ferric oxide yellow |
cimetidine 400 MG [Ultec] (Clinical Drug) something which constitutes Ultec 400 MG Oral Tablet |
chr22 (Chromosomes) Genes which is chromosome involved in cytogenetic abnormality t(9;22)(q34.1;q11.2) |
Western European tick-borne encephalitis (Tick-borne flavivirus encephalitis) Viral Encephalitis which has causative agent European tick-borne encephalitis virus |
Leiomyosarcoma and Endometrial Stromal Sarcoma pT1a TNM Finding v7 (Leiomyosarcoma and Endometrial Stromal Sarcoma pT1 TNM Finding v7) Leiomyosarcoma and Endometrial Stromal Sarcoma pT1 TNM Finding v7 which is a Leiomyosarcoma and Endometrial Stromal Sarcoma pT1 TNM Finding v7 |
writing compensatory strategies for sequencing (Therapeutic or Preventive Procedure) Therapeutic or Preventive Procedure which is a language therapy writing compensatory strategies |
Loose body in left ankle joint (Acquired Abnormality) Acquired Abnormality which has associated morphology Loose body |
Haematological malignant tumours (Classification) Classification which has member Leukemic reticuloendotheliosis involving lymph nodes of multipes sites |
Complete rupture (Complete disruption) Injury or Poisoning which is associated morphology of Complete tear of wrist ligament |
Other specified diagnostic endoscopic examination of ventricle of brain (Diagnostic surgical procedure) Cerebral ventriculotomy which has procedure site Brain tissue |
Azithromycin 250 MG Oral Tablet, Includes 6 Count Pack (Drug Delivery Device) something which includes AZITHROMYCIN DIHYDRATE 250 mg ORAL TABLET, FILM COATED [Azithromycin Dihydrate] |
Congenital Abnormality (Congenital abnormal shape, NOS) Disorders, General, Functional and NEC which is associated morphology of Mobius Syndrome |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.